Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

The intersection of biotechnology, advanced materials, and molecular biology

Kraig Biocraft Laboratories is developing genetically engineered silkworms capable of producing spider silk at scale The company believes it has built the only viable platform for continuous recombinant spider silk filament Production is ramping towar...
Ricki Lee | 4 days ago |

One of Africa’s most prolific gold districts — the Lake Victoria Gold Fields

This is The Capital Compass. Today we’re heading to one of Africa’s most prolific gold districts — the Lake Victoria Gold Fields — to take a closer look at Cameo Resources ( CSE:MEO ) and its Katoro Project. This is a region that has ...
Ricki Lee | March 19, 2026 |

Oregen Energy: Walking in the footsteps of giants

Oregen Energy Corp ., a high potential energy story in the Namibia. This is a company who is walking in the footsteps of giants, but with a market cap that leaves far more upside on the table compared to the super majors in the region. They’ve assembled a...
Lyndsay Malchuk | August 29, 2025 |

New Analyst Report Lifts Almonty Target Price to CDN$5.50

Almonty Industries Inc. —a tungsten play that’s gone from obscure critical minerals junior to one of the most closely watched names in the Western supply chain realignment. Fresh off shareholder approval to redomicile to the U.S., Almonty is charging...
Lyndsay Malchuk | June 12, 2025 |

Turning Plastic Waste into a Commercial-Grade Renewable Green Condensate

PlasCred Circular Innovations is turning plastic garbage into a commercial-grade product — and doing it in a way that challenges how we think about recycling. Lyndsay Malchuk recently caught up with President and CEO Troy Lupul, to spotlight the who, what and how it&Clo...
Lyndsay Malchuk | May 22, 2025 |

On the Ground at Bauma: dynaCERT Walks the Talk on Clean-Tech Innovation

Lyndsay Malchuk from Stockhouse Publishing was on the ground at the world-renowned Bauma show in Munich, Germany — the largest trade show of its kind, drawing innovators and leaders from the construction, mining, and heavy equipment sectors worldwide. Among the many atten...
Lyndsay Malchuk | April 23, 2025 |

GBC Backs Almonty's Tungsten Push As Game-Changer

GBC Investment Research is one of the lea­ding bank-in­de­pen­dent in­vest­ment hou­ses in Ger­ma­ny and an ex­pe­ri­en­ced is­suing ex­pert for Ger­man SMEs. As an ow­ner-ma­na­ged com­pa­ny, GBC AG knows the fi­nan­cing needs of Ger­man SMEs and is an in­de­pen­d...
Lyndsay Malchuk | April 16, 2025 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Buzz on the Bullboards: Where volatility meets opportunity

It has been a wild ride for markets on Bay Street and Wall Street this week. Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. It is reporting season for many companies, and Stockhouse users seem...
Jonathon Brown | February 15, 2024 |

ExoTherapy offers hope for treating acute spinal cord injuries

Suffering from traumatic injuries can leave a person with long-term damages and/or side effects that are hard to navigate long after the initial incident has passed. Our next company is a publicly traded bio-pharmaceutical company, working on the development of its ...
Brieanna McCutcheon | September 19, 2023 |
1 2 3 4